Free Account Opening + AMC Free Demat
Loading...

Eris Lifesciences IPO vs SiS IPO

Comparision between Eris Lifesciences IPO and SiS IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while SiS IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the SiS IPO is up to ₹779.58 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of SiS IPO is ₹815.00 per share.

  Eris Lifesciences IPO SiS IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹600.00 per share ₹805.00 per share
Issue Price (Upper) ₹603.00 per share ₹815.00 per share
Issue Price (Final) ₹603.00 per share ₹815.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 18 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹362.25 Cr
OFS Issue Size 2,88,75,000 shares 51,20,619 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 95,65,404 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹779.58 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while SiS IPO opens on Jul 31, 2017. The closing date of Eris Lifesciences IPO and SiS IPO is Jun 20, 2017, and Aug 02, 2017, respectively.

  Eris Lifesciences IPO SiS IPO
Anchor Bid Date
Issue Open Jun 16, 2017 Jul 31, 2017
Issue Close Jun 20, 2017 Aug 02, 2017
Basis Of Allotment (Tentative) Jun 23, 2017 Aug 07, 2017
Initiation of Refunds (Tentative) Jun 27, 2017 Aug 08, 2017
Credit of Share (Tentative) Jun 28, 2017 Aug 09, 2017
Listing date (Tentative) Jun 29, 2017 Aug 10, 2017
Anchor Lockin End date 1 Jul 23, 2017 Sep 06, 2017
Anchor Lockin End date 2 Sep 21, 2017 Nov 05, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to SiS IPO P/E ratio of .

  Eris Lifesciences IPO SiS IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 5,173.28 4,393.85 3,629.42 3,038.69 2,370.46
Total Revenue 12,873.22 10,562.87 8,244.94 5,826.73 4,648.84
Profit After Tax 339.08 246.38 332.15 298.93 110.53
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in SiS IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 29,11,034 shares in SiS IPO.

  Eris Lifesciences IPO SiS IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 29,11,034 shares
NII 43,08,750 shares 14,43,092 shares
RII 28,72,500 shares 9,62,061 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 53,16,187 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas SiS IPO subscribed 7.07x.

  Eris Lifesciences IPO SiS IPO
QIB (times) 4.68x 5.64x
NII (times) 0.45x 1.66x
Big NII (times)
Small NII (times)
RII (times) 3.51x 19.51x
Employee (times) 0.86x
Other (times)
Total (times) 3.29x 7.07x

Comments

Add a public comment...